How to Read a Peptide COA Without Getting Fooled

Disclosure: Peptide Bio Index is affiliated with SourcePoint Research and may earn from qualifying purchases or affiliate links.

A Certificate of Analysis (COA) is a document supplied with a batch of synthetic peptide material that reports analytical test results and release information. This guide explains how to read common COA elements, practical verification checks to ask for, and red flags to watch for.

What a COA typically identifies

An authentic COA should identify the material and batch tested, list each test performed, provide acceptance limits and numerical results, and name the authorized issuer for the result reported. ^[S5]

Common tests reported on peptide COAs include liquid-chromatography–mass-spectrometry (LC-MS/MS) for mass and sequence confirmation, reversed-phase HPLC-UV for chromatographic purity and impurity quantitation, and separate assays for peptide content (e.g., amino-acid analysis), counterions, residual solvents, and chirality. ^{[S2] [S1]}

How identity and purity are usually documented

Peptide identity is commonly confirmed by mass spectrometry and/or LC-MS/MS, whereas chromatographic purity is typically assessed by reversed-phase HPLC-UV; these are complementary approaches used together to support quality claims. ^{[S1] [S2] [S3]}

Chromatographic purity is not the same as net peptide content: steep chromatographic gradients can cause co-elution that masks impurities, and peptide content (net amount of peptide) is measured by separate methods such as amino-acid analysis. ^{[S1] [S2]}

What a COA can and cannot prove

A COA documents analytical measurements for a specific batch and can show which tests were performed and their numerical outcomes; when linked to validated methods and raw data, it supports determinations about identity, purity, and certain quality attributes for that batch. ^{[S5] [S4]}

A COA alone cannot, by itself, establish broader claims such as long-term stability beyond reported data, clinical safety or efficacy, or full manufacturing control unless the COA is supported by retained laboratory records, validated procedures, and appropriate accreditation. ^{[S5] [S6] [S4]}

Practical verification checks to ask for on a COA

Confirm the COA names the material and batch, lists each test with acceptance criteria and numerical results, and shows an authorized issuer and release status; these elements are recommended for an authentic certificate. ^[S5]

Check that methods are named and, where possible, that they have been validated or shown fit-for-purpose in line with analytical validation guidance (ICH Q2(R2)), rather than presenting unexplained numerical values. ^[S4]

Request the primary/raw data that underlies reported results—original chromatograms, mass spectra, and any calculation worksheets—because laboratory records should retain raw data tied to the batch tested. ^{[S5] [S1]}

Look for laboratory accreditation (for example to ISO/IEC 17025) and documented metrological traceability for quantitative measurements; accreditation and traceability add context to the credibility of third‑party COAs and measurement claims. ^{[S6] [S7]}

Red flags and ambiguous presentations

A single percentage purity claim without an accompanying chromatogram or MS spectra, unspecified methods, or missing batch identification should prompt further inquiry, as those omissions limit what the COA can substantiate. ^{[S5] [S1]}

Reporting chromatographic purity obtained with steep gradients without showing chromatograms can mask co‑eluting impurities; absence of orthogonal tests for content (for example, no amino‑acid analysis) can leave net peptide amount unclear. ^{[S1] [S2]}

Claims of traceability or accreditation that are not supported by documentation (e.g., an accreditation certificate or chain-of-calibration records) are ambiguous and should be verified. ^{[S7] [S6]}

Interpreting methods and validation statements

Where the COA names methods, check whether the methods are appropriate for the intended measurement (identity, purity, content, impurities) and whether method performance characteristics—specificity, accuracy, precision and range—are documented per validation guidance. ^{[S4] [S2]}

If method validation details are not provided on the COA, ask whether the laboratory has validated the procedure for the intended purpose and whether validation documentation or summaries are available. ^{[S4] [S5]}

Retention of records and traceability

Good practice guidance and regulatory recommendations state that laboratory records should retain raw data, chromatograms, graphs, and spectra linked to the batch tested; this linkage is important for auditability and traceability of measurement results. ^{[S5] [S7]}

Limitations and research gaps

• A COA documents analytical results for a specific batch and cannot substitute for full manufacturing records or establish broader product claims without supporting documentation.
• Some COAs present summary values without method details or raw data; those summaries provide limited evidence unless methods, validation, and raw data are available for review.
• Accreditation, traceability, and retained raw data strengthen COA credibility, but their absence does not by itself prove a COA is fraudulent—rather, it limits what the COA can substantiate.

Documentation checklist

• Does the COA name the material and batch ID?
• Does it list each test with numerical results and acceptance limits?
• Are the analytical methods named and are validation or fit-for-purpose statements available?
• Can the issuer provide raw chromatograms and mass spectra linked to the batch?
• Is the testing laboratory accredited (e.g., ISO/IEC 17025) and are traceability claims documented?

Related research supplies

• Request form for raw chromatograms and spectra
• Checklist for COA review and method verification
• Template request for laboratory accreditation and traceability documentation

Sources and references

1. [S1] Recommendations for the Generation, Quantification, Storage and Handling of Peptides Used for Mass Spectrometry-Based Assays. primary literature. PMID:
2. [S2] Reference Standards to Support Quality of Synthetic Peptide Therapeutics. primary literature. PMID:
3. [S3] Guidance for Industry: Synthetic Peptides. official. PMID:
4. [S4] Q2(R2) Validation of Analytical Procedures. official. PMID:
5. [S5] Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. official. PMID:
6. [S6] ISO/IEC 17025:2017 — General Requirements for the Competence of Testing and Calibration Laboratories. standards. PMID:
7. [S7] Metrological Traceability: Frequently Asked Questions and NIST Policy. official. PMID:

Peptide Bio Index is affiliated with SourcePoint Research. Articles may link to SourcePointResearch.com and third-party affiliate products. As an Amazon Associate, Peptide Bio Index earns from qualifying purchases. Content is educational and research-literature focused only and is not medical advice, dosing guidance, or a personal-use recommendation.